Tag: Novartis

Health Innovation Study Technology The world

Pharming announces positive results of Phase II/III for the treatment of activated PI3K delta syndrome

2 min read

Leiden, The Netherlands,Business News: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/NASDAQ: PHAR) announces positive results from the pivotal Phase II/III blinded randomized, placebo-controlled registration-enabling

Read More

Share

You May Have Missed

UAE

UAE’s Commitment to GCC Economic Integration Highlighted at Trade and Industry Meetings

Banks

Emirates NBD observes UAE Flag Day

Business News

Otaxi Signs Strategic Partnership Agreement with ITHCA Group and Yango Group To Elevate Taxi Services in Oman

Lifestyle

Longevity Wellness Hub Expands with Five New State-of-the-Art Facilities Across the GCC